https://orcid.org/0000-0003-3418-3362
References
- Young CA, Ealing J, McDermott CJ, Williams TL, Al-Chalabi A, Majeed T, et al. Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months. Amyotroph Lateral Scler Frontotemporal Degener. 2022;1–9.
- Thakore NJ, Pioro EP. Depression in ALS in a large self-reporting cohort. Neurology 2016;86:1031–8.
- Katzan IL, Lapin B, Griffith S, Jehi L, Fernandez H, Pioro E, et al. Somatic symptoms have negligible impact on Patient Health Questionnaire-9 depression scale scores in neurological patients. Eur J Neurol. 2021;28:1812–9.
- Cameron IM, Crawford JR, Lawton K, Reid IC. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. Br J Gen Pract. 2008;58:32–6.
- Vázquez Medrano CR, Aho-Özhan HEA, Weiland U, Uttner I, Ludolph AC, Lulé D. Disease progression but not physical state per se determines mental wellbeing in ALS. J Neurol. 2020;267:3593–601.
- Goldberg D. Plato versus Aristotle: categorical and dimensional models for common mental disorders. Compr Psychiatry. 2000;41:8–13.